Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)
Trial ID or NCT#
NCT01631331
Status
NOT RECRUITING
Purpose
The purpose of this study is to learn about the effect of vismodegib on sporadic basal cell carcinoma (BCCs) prior to surgical removal.
Official Title
A Pilot Study to Investigate the Off Label Use of Vismodegib as an Adjuvant to Surgery for Basal Cell Carcinoma Tumors (BCCs)
Investigator(s)
Anthony Oro, MD, PhD
Dermatologist,
Hair loss specialist,
Dermatologic oncologist,
Cutaneous oncology specialist,
Skin stem cell specialist
Eugene and Gloria Bauer Professor
Jean Y Tang
General dermatologist,
Dermatologic oncologist,
Dermatologist,
Cutaneous oncology specialist
Professor of Dermatology
Contact us to find out if this trial is right for you.
Contact
ccto-office@stanford.edu
650-498-7061
View on ClinicalTrials.gov
